共 30 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 37835-471-75 | BI-MART Ultra Strength Antacid Peppermint | TABLET, CHEWABLE | 2019-03-21 | M001 |
| 2 | 37835-115-17 | BI-MART Regular Strength Antacid Peppermint | TABLET, CHEWABLE | 2019-03-20 | M001 |
| 3 | 37835-126-17 | BI-MART Regular Strength Antacid | TABLET, CHEWABLE | 2019-03-21 | M001 |
| 4 | 37835-127-22 | Bi-Mart Extra Strength Antacid Assorted Fruit | TABLET, CHEWABLE | 2019-03-15 | M001 |
| 5 | 37835-171-75 | Bi-Mart Ultra Strength Antacid Assorted Fruit | TABLET, CHEWABLE | 2019-03-19 | M001 |
| 6 | 37835-184-22 | Bi-Mart Extra Strength Antacid Assorted Berry | TABLET, CHEWABLE | 2018-09-26 | M001 |
| 7 | 37835-233-18 | EXTRA STRENGTH SIMETHICONE | TABLET, CHEWABLE | 2025-09-01 | M002 |
| 8 | 37835-231-72 | Extra Strength Simethicone | CAPSULE, LIQUID FILLED | 2025-04-01 | M002 |
| 9 | 37835-903-01 | Triple Antibiotic | OINTMENT | 2024-07-01 | M004 |
| 10 | 37835-904-01 | Triple Antibiotic Plus Pain Relief | OINTMENT | 2024-07-01 | M004 |
| 11 | 37835-223-01 | STOOL SOFTENER | CAPSULE, LIQUID FILLED | 2025-03-01 | M007 |
| 12 | 37835-207-48 | STOMACH RELIEF | TABLET | 2025-06-01 | M008 |
| 13 | 37835-202-01 | MECLIZINE | TABLET, CHEWABLE | 2026-01-14 | M009 |
| 14 | 37835-852-50 | Diphenhydramine HCl Maximum Strength | TABLET | 2025-05-01 | M010 |
| 15 | 37835-520-24 | Daytime Cold and Flu Relief | CAPSULE, LIQUID FILLED | 2025-03-01 | M012 |
| 16 | 37835-522-24 | Nighttime Cold and Flu Relief | CAPSULE, LIQUID FILLED | 2025-03-01 | M012 |
| 17 | 37835-641-01 | Diphenhydramine Hydrochloride | TABLET | 2025-02-01 | M012 |
| 18 | 37835-633-01 | Allergy | TABLET | 2026-02-01 | M012 |
| 19 | 37835-647-01 | Allergy Medicine | CAPSULE | 2025-06-01 | M012 |
| 20 | 37835-651-01 | Nasal Decongestant PE | TABLET | 2025-03-01 | M012 |
| 21 | 37835-812-36 | NIGHTTIME SLEEP AID | TABLET | 2025-05-01 | M012 |
| 22 | 37835-995-34 | NASAL | SPRAY | 2024-05-16 | M012 |
| 23 | 37835-996-01 | Oxymetazoline Hydrochloride | SPRAY | 2025-08-01 | M012 |
| 24 | 37835-507-01 | Acetaminophen Extra Strength | TABLET | 2025-05-01 | M013 |
| 25 | 37835-531-01 | Acetaminophen, Aspirin, and Caffeine | TABLET | 2025-02-01 | M013 |
| 26 | 37835-573-36 | Low Dose Chewable Aspirin | TABLET, CHEWABLE | 2025-10-01 | M013 |
| 27 | 37835-537-01 | Acetaminophen and Diphenhydramine Hydrochloride | TABLET | 2025-02-01 | M013 |
| 28 | 37835-571-05 | Adult Low Dose Enteric Coated Aspirin | TABLET, DELAYED RELEASE | 2025-03-01 | M013 |
| 29 | 37835-577-01 | Aspirin | TABLET, FILM COATED | 2025-08-01 | M013 |
| 30 | 37835-998-01 | Saline | SPRAY | 2025-06-01 | M022 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系